A Comparative Study of Replication-Incompetent and -Competent Adenoviral Therapy-Mediated Immune Response in a Murine Glioma Model-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Comparative Study of Replication-Incompetent and -Competent Adenoviral Therapy-Mediated Immune Response in a Murine Glioma Model

Published:2017-06 Issue: Volume:5 Page:97-104
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Kim Julius W.,Miska Jason,Young Jacob S.,Rashidi Aida,Kane J. Robert,Panek Wojciech K.,Kanojia Deepak,Han Yu,Balyasnikova Irina V.,Lesniak Maciej S.

Funder

NIH

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference36 articles.

1. Unlocking the promise of oncolytic virotherapy in glioma: combination with chemotherapy to enhance efficacy;Spencer;Ther. Deliv.,2015

2. Sui generis: gene therapy and delivery systems for the treatment of glioblastoma;Kane;Neuro-oncol.,2015

3. Oncolytic virotherapy for malignant glioma: translating laboratory insights into clinical practice;Auffinger;Front. Oncol.,2013

4. Oncolytic virotherapy for gliomas: steps toward the future;Kaufmann;CNS Oncol.,2013

5. A phase I trial of intravenous infusion of ONYX-015 and Enbrel in solid tumor patients;Nemunaitis;Cancer Gene Ther.,2007

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineered Oncolytic Adenoviruses: An Emerging Approach for Cancer Therapy;Pathogens;2022-10-04

2. ErbB3-Targeting Oncolytic Adenovirus Causes Potent Tumor Suppression by Induction of Apoptosis in Cancer Cells;International Journal of Molecular Sciences;2022-06-27

3. A new insight into aggregation of oncolytic adenovirus Ad5-delta-24-RGD during CsCl gradient ultracentrifugation;Scientific Reports;2021-08-09

4. Immunovirotherapy for the Treatment of Glioblastoma and Other Malignant Gliomas;Neurosurgery Clinics of North America;2021-04

5. Polyamines drive myeloid cell survival by buffering intracellular pH to promote immunosuppression in glioblastoma;Science Advances;2021-02-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3